Literature DB >> 30415419

Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis.

Xiao-Qing Yang1, Yan-Jie Huang2, Wen-Sheng Zhai1, Xian-Qing Ren1, Qing-Yin Guo1, Xia Zhang1, Meng Yang1, Jian Zhang1, Ying Ding1, Shan Zhu3, Tatsuo Yamamoto4, Yuan Sun5.   

Abstract

BACKGROUND: The endocapillary proliferative (EP) lesion is not included in the International Study of Kidney Disease in Children (ISKDC) pathological classification of Henoch-Schönlein purpura nephritis (HSPN). The main objective of the study was to determine the pathological importance of EP in the development of proteinuria in children with Henoch-Schönlein purpura nephritis (HSPN).
METHODS: The pathological features of 148 HSPN children with nephrotic-range proteinuria were investigated retrospectively. Urinary IgG, transferrin, and albumin levels were measured by immunonephelometry. The correlations between EP lesion and 24-h proteinuria, urinary IgG, urinary transferrin, and urinary albumin were analyzed. Renal biopsy specimens were immunohistochemically stained for nephrin and podocalyxin.
RESULTS: Of the total 581 cases of children with HSPN who underwent renal biopsy, 148 cases (25.5%) presented with nephrotic-range proteinuria. The pathological types of HSPN with nephrotic-range proteinuria were categorized as IIb, IIIa, IIIb, IIIb with diffuse EP, IVb, pure focal EP type, and pure diffuse EP type. Among these types, pure diffuse EP type accounted for 7.4%. The levels of 24-h proteinuria and urinary albumin were the highest in pure diffuse EP type among all pathological types, and the percentage of EP correlated with 24-h proteinuria and urinary albumin levels. 24-h proteinuria was significantly higher in pure diffuse EP type relative to HSPN IIb type, and significantly higher in IIIb with EP, compared with HSPN IIIb. Nephrin, but not podocalyxin, was downregulated in EP segment.
CONCLUSIONS: EP is an independent pathogenic factor in HSPN with nephrotic-range proteinuria. Downregulation of nephrin in EP segment is a potential molecular mechanism of nephrotic-range proteinuria. Albumin is the major urinary protein component in HSPN with EP.

Entities:  

Keywords:  Endocapillary proliferative; HSPN; Nephrotic-range proteinuria

Mesh:

Substances:

Year:  2018        PMID: 30415419     DOI: 10.1007/s00467-018-4134-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  23 in total

1.  Commentary on the KDIGO clinical practice guideline for glomerulonephritis.

Authors:  Chen Au Peh
Journal:  Nephrology (Carlton)       Date:  2013-07       Impact factor: 2.506

2.  Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis.

Authors:  Shasha Chen; Zheng Tang; Yiyan Zhang; Zhengzhao Liu; Haitao Zhang; Weixin Hu; Zhihong Liu
Journal:  Am J Nephrol       Date:  2013-11-13       Impact factor: 3.754

3.  Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases.

Authors:  Shi-Xuan Wang; Maria P Rastaldi; Anu Pätäri; Heikki Ahola; Eija Heikkilä; Harry Holthöfer
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

4.  Hypertension increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin in normoalbuminuric patients with type 2 diabetes mellitus.

Authors:  Nobumasa Ohara; Osamu Hanyu; Satoshi Hirayama; Osamu Nakagawa; Yoshifusa Aizawa; Seiki Ito; Hirohito Sone
Journal:  J Hypertens       Date:  2014-02       Impact factor: 4.844

Review 5.  Postinfectious glomerulonephritis.

Authors:  Neeraja Kambham
Journal:  Adv Anat Pathol       Date:  2012-09       Impact factor: 3.875

6.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

7.  Henoch-Schönlein nephritis: a nationwide study.

Authors:  O Soylemezoglu; O Ozkaya; S Ozen; A Bakkaloglu; R Dusunsel; H Peru; A Cetinyurek; N Yildiz; O Donmez; N Buyan; S Mir; N Arisoy; A Gur-Guven; H Alpay; M Ekim; N Aksu; A Soylu; F Gok; H Poyrazoglu; F Sonmez
Journal:  Nephron Clin Pract       Date:  2009-05-13

Review 8.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

9.  Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell.

Authors:  D Kerjaschki; D J Sharkey; M G Farquhar
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein purpura nephritis in children.

Authors:  Haidong Fu; Jianhua Mao; Yanping Xu; Weizhong Gu; Xiujuan Zhu; Aimin Liu
Journal:  Clinics (Sao Paulo)       Date:  2016-09       Impact factor: 2.365

View more
  2 in total

1.  The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children.

Authors:  Yan Jin; Yanzheng Wang; Sai Wang; Qiongqiong Zhao; Donghua Zhang; Xuan Feng
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-21       Impact factor: 2.629

2.  Construction and internal validation of a predictive model for risk of gastrointestinal bleeding in children with abdominal Henoch-Schönlein purpura: A single-center retrospective case-control study.

Authors:  Lingli Sun; Wenjuan Liu; Changjian Li; Yong Zhang; Yuanyuan Shi
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.